Literature DB >> 2694822

The immune response of humans to live and inactivated influenza vaccines.

Y Ghendon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2694822     DOI： 10.1007/978-1-4684-5712-4_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Authors:  B S Bender; C A Rowe; S F Taylor; L S Wyatt; B Moss; P A Small
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.

Authors:  Joseph N Brewoo; Tim D Powell; Jeremy C Jones; Nancy A Gundlach; Ginger R Young; Haiyan Chu; Subash C Das; Charalambos D Partidos; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2013-02-01       Impact factor: 3.641

3.  Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.

Authors:  Subash C Das; Masato Hatta; Peter R Wilker; Andrzej Myc; Tarek Hamouda; Gabrielle Neumann; James R Baker; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2012-09-16       Impact factor: 3.641

4.  Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  Mineo Watanabe; Masaaki Nagai
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

5.  Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.

Authors:  J D Barackman; G Ott; D T O'Hagan
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.

Authors:  Sapna Patel; Yasser Faraj; Debra K Duso; William W Reiley; Erik A Karlsson; Stacey Schultz-Cherry; Michael Vajdy
Journal:  Nutrients       Date:  2017-05-21       Impact factor: 5.717

7.  Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors:  Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

8.  Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization.

Authors:  J D Barackman; G Ott; S Pine; D T O'Hagan
Journal:  Clin Diagn Lab Immunol       Date:  2001-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.